Using its heat-treatment-free 3-D printing process,
Amnovis — a leading Belgian manufacturer of 3-D printed titanium implants — has reached a significant milestone, delivering over 50,000 titanium implants since 2021. The company says its ‘innovative technology’ is transforming the production of spinal, orthopaedic, and cranio-maxillofacial (CMF) implants, allowing customers to benefit from ‘unmatched production speed, cost efficiency, and reduced time to market’.
Ruben Wauthle, Amnovis’s CEO and co-founder, said: “We developed and validated a proprietary process for pure titanium that requires no heat treatment. This unique process allows us to deliver faster, more cost-effective solutions for our customers while maintaining the highest quality standards.”
Privelop-Spine CEO Henning Kloss, one of Amnovis’s partners that has benefitted from this process — said: “Since partnering with Amnovis, we have been impressed by their production quality and specialist expertise. Surgeons consistently praise the detailed resolution, look, and feel of our implant structures, while distributors and users appreciate the reliability and punctual delivery.
“Amnovis’s heat-treatment-free titanium process has significantly streamlined our production, reducing time and costs. Their production capacity and reliability have made a substantial contribution to our collaboration with large customers, helping us bring products to market faster.”
In addition to its heat-treatment-free process, Amnovis offers a full range of traditional titanium 3-D printing services, including Ti-6Al-4V grade 23 with classical heat treatments such as HIP (hot isostatic pressing), giving OEMs the flexibility to choose the most suitable manufacturing method for their needs.